Page 15 - Read Online

factor and α9β1 integrin in glial tumor angiogenesis. Neuro Oncol 20. MacDonald TJ, Taga T, Shimada H, Tabrizi P, Zlokovic BV,
2012;14:890‑901. Cheresh DA, Laug WE. Preferential susceptibility of brain tumors
15. Dimitropoulos K, Giannopoulou E, Argyriou AA, Zolota V, Petsas T, to the antiangiogenic effects of an alpha(v) integrin antagonist.
Tsiata E, Kalofonos HP. The effects of anti‑VEGFR and anti‑EGFR Neurosurgery 2001;48:151‑7.
agents on glioma cell migration through implication of growth factors 21. Tabatabai G, Weller M, Nabors B, Picard M, Reardon D, Mikkelsen T,
with integrins. Anticancer Res 2010;30:4987‑92. Ruegg C, Stupp R. Targeting integrins in malignant glioma. Target
16. Binder BR, Mihaly J, Prager GW. uPAR‑uPA‑PAI‑1 interactions Oncol 2010;5:175‑81.
and signaling: a vascular biologist’s view. Thromb Haemost 22. Sugahara KN, Teesalu T, Karmali PP, Kotamraju VR, Agemy L,
2007;97:336‑42. Girard OM, Hanahan D, Mattrey RF, Ruoslahti E. Tissue‑penetrating
17. Desgrosellier JS, Cheresh DA. Integrins in cancer: biological implications delivery of compounds and nanoparticles into tumors. Cancer Cell
and therapeutic opportunities. Nat Rev Cancer 2010;10:9‑22. 2009;16:510‑20.
18. Xiong JP, Stehle T, Zhang R, Joachimiak A, Frech M, Goodman SL,
Arnaout MA. Crystal structure of the extracellular segment of integrin
alpha Vbeta3 in complex with an Arg‑Gly‑Asp ligand. Science Cite this article as: Giannopoulou E, Tzakos A, Argyriou AA. Integrins and
focal adhesion kinase in the malignant behavior of gliomas. Neuroimmunol
2002;296:151‑5. Neuroinflammation 2015;2(1):4-7.
19. Nisato RE, Tille JC, Jonczyk A, Goodman SL, Pepper MS. alphav Source of Support: Nil. Conflict of Interest: No.
beta 3 and alphav beta 5 integrin antagonists inhibit angiogenesis
in vitro. Angiogenesis 2003;6:105‑19. Received: 01-09-2014; Accepted: 16-10-2014

Neuroimmunol Neuroinflammation | Volume 2 | Issue 1 | January 15, 2015 7